213 related articles for article (PubMed ID: 32277725)
21. RB1 5́UTR contains an IRES related to cell cycle control and cancer progression.
Ma W; Ma B; Ma J; Zhu R
Gene; 2023 Dec; 887():147724. PubMed ID: 37604323
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
23. Defective splicing of the RB1 transcript is the dominant cause of retinoblastomas.
Cygan KJ; Soemedi R; Rhine CL; Profeta A; Murphy EL; Murray MF; Fairbrother WG
Hum Genet; 2017 Sep; 136(9):1303-1312. PubMed ID: 28780672
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous identification of clinically relevant
Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
[TBL] [Abstract][Full Text] [Related]
26. RB1: a prototype tumor suppressor and an enigma.
Dyson NJ
Genes Dev; 2016 Jul; 30(13):1492-502. PubMed ID: 27401552
[TBL] [Abstract][Full Text] [Related]
27. Increased efficiency in the generation of induced pluripotent stem cells by Fbxw7 ablation.
Okita Y; Matsumoto A; Yumimoto K; Isoshita R; Nakayama KI
Genes Cells; 2012 Sep; 17(9):768-77. PubMed ID: 22897623
[TBL] [Abstract][Full Text] [Related]
28.
Marshall AE; Roes MV; Passos DT; DeWeerd MC; Chaikovsky AC; Sage J; Howlett CJ; Dick FA
Mol Cell Biol; 2019 Aug; 39(16):. PubMed ID: 31138663
[TBL] [Abstract][Full Text] [Related]
29. Reprogramming of retinoblastoma cancer cells into cancer stem cells.
Yue F; Hirashima K; Tomotsune D; Takizawa-Shirasawa S; Yokoyama T; Sasaki K
Biochem Biophys Res Commun; 2017 Jan; 482(4):549-555. PubMed ID: 27856246
[TBL] [Abstract][Full Text] [Related]
30. Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.
Tu J; Huo Z; Liu M; Wang D; Xu A; Zhou R; Zhu D; Gingold J; Shen J; Zhao R; Lee DF
Stem Cell Res; 2018 Apr; 28():29-32. PubMed ID: 29414415
[TBL] [Abstract][Full Text] [Related]
31. Inducing Pluripotency in the Domestic Cat (
Dutton LC; Dudhia J; Guest DJ; Connolly DJ
Stem Cells Dev; 2019 Oct; 28(19):1299-1309. PubMed ID: 31389301
[TBL] [Abstract][Full Text] [Related]
32. Detection and reporting of RB1 promoter hypermethylation in diagnostic screening.
Price EA; Kolkiewicz K; Patel R; Hashim S; Karaa E; Scheimberg I; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2018 Aug; 39(4):526-531. PubMed ID: 29851531
[TBL] [Abstract][Full Text] [Related]
33. Unilateral retinocytoma associated with a variant in the RB1 gene.
Wu S; Zou X; Sun Z; Zhu T; Wei X; Sui R
Mol Genet Genomic Med; 2020 Apr; 8(4):e1156. PubMed ID: 31997559
[TBL] [Abstract][Full Text] [Related]
34. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
[No Abstract] [Full Text] [Related]
35. Cells Lacking the
Oser MG; Fonseca R; Chakraborty AA; Brough R; Spektor A; Jennings RB; Flaifel A; Novak JS; Gulati A; Buss E; Younger ST; McBrayer SK; Cowley GS; Bonal DM; Nguyen QD; Brulle-Soumare L; Taylor P; Cairo S; Ryan CJ; Pease EJ; Maratea K; Travers J; Root DE; Signoretti S; Pellman D; Ashton S; Lord CJ; Barry ST; Kaelin WG
Cancer Discov; 2019 Feb; 9(2):230-247. PubMed ID: 30373918
[TBL] [Abstract][Full Text] [Related]
36.
Kanber D; Woestefeld J; Döpper H; Bozet M; Brenzel A; Altmüller J; Kilpert F; Lohmann D; Pommerenke C; Steenpass L
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565295
[TBL] [Abstract][Full Text] [Related]
37. Human Fibrinogen for Maintenance and Differentiation of Induced Pluripotent Stem Cells in Two Dimensions and Three Dimensions.
Gandhi JK; Knudsen T; Hill M; Roy B; Bachman L; Pfannkoch-Andrews C; Schmidt KN; Metko MM; Ackerman MJ; Resch Z; Pulido JS; Marmorstein AD
Stem Cells Transl Med; 2019 Jun; 8(6):512-521. PubMed ID: 30768863
[TBL] [Abstract][Full Text] [Related]
38. Lack of correlation between age at diagnosis and RB1 mutations for unilateral retinoblastoma: the importance of genetic testing.
Berry JL; Lewis L; Zolfaghari E; Green S; Le BHA; Lee TC; Murphree AL; Kim JW; Jubran R
Ophthalmic Genet; 2018 Jun; 39(3):407-409. PubMed ID: 29286867
[No Abstract] [Full Text] [Related]
39. Bilateral retinoblastoma with one eye manifesting only posterior chamber infiltration and no retinal involvement.
Ossandon D; Kastner A; Zanolli M; Solanes F; Pérez V; Repetto G; Benavides F; Shields CL
J AAPOS; 2016 Dec; 20(6):548-550.e1. PubMed ID: 27815188
[TBL] [Abstract][Full Text] [Related]
40. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
